At Memorial Sloan Kettering Cancer Center, our world-renowned cancer researchers, oncologists, clinicians, and scientists are constantly advancing our knowledge about cancer. Our discoveries are improving treatment and care for patients here and all over the world. On this page, you will find news & information about our latest groundbreaking cancer science, exceptional patient care and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
Over the last seven and a half decades, researchers at the Sloan Kettering Institute have made important contributions to the fundamental understanding of human biology, as well as driven practice-changing innovations in the treatment of cancer.
Memorial Sloan Kettering Cancer Center is proud to announce that Ross Levine, MD, and Dana Pe’er, PhD, have been elected to the National Academy of Medicine, one of the highest honors in science and medicine.
MSK and OpenEvidence have announced a new partnership to advance precision oncology by integrating OpenEvidence into MSK’s clinical workflow and expanding access to OncoKB™, MSK’s FDA-recognized precision oncology knowledge base, for providers nationwide. Together, the collaboration aims to deliver AI-powered clinical insights and support more informed decision-making in complex cancer care.
MSK Kids, the pediatric oncology program at Memorial Sloan Kettering Cancer Center (MSK), has been named one of the best children's hospitals nationally by U.S. News & World Report in its annual "Best Children's Hospitals" list.
We understand at MSK that caregivers play an essential role in the well-being of our patients. In this issue, meet people whose stories reveal the power of compassion, collaboration, and showing up when it matters most.
The FDA approved a treatment for rectal cancer tumors with a specific genetic signature that uses only the immunotherapy Jemperli, allowing some patients to be successfully treated without surgery, radiation, or chemotherapy.
A new study found that consuming high levels of sugar while taking antibiotics appears to worsen common gastrointestional side effects in patients receiving bone marrow transplants.
After a cancer diagnosis, one of the first and toughest decisions people face is how much to share in the workplace. Read more about working with cancer — and how MSK offers guidance and support.
Learn how MSK is making clinical trials more accessible through innovative new approaches that bring care to people's homes and make participating possible even for people who live far from MSK.
Every year, thousands of people travel from across the country and around the world in search of hope at MSK. Learn how MSK supports patients far from home.
Cancer Straight Talk brings together national experts and cancer patients to have straightforward, evidence-based conversations. Its mission is to educate and empower cancer patients and their families to make the right decisions and live happier, healthier lives.
